Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14076 - 14100 of 14641 in total
ND1251 is an orally active phosphodiesterase-4 (PDE4) inhibitor, a mechanism clinically proven to play a role in alleviating symptoms of depression. ND1251 is a very potent compound with a large safety margin. ND1251 may also have applications in other disorders, such as Alzheimer's disease, mild cognitive impairment, multiple sclerosis and...
Investigational
Matched Description: … applications in other disorders, such as Alzheimer's disease, mild cognitive impairment, multiple sclerosis and
An anticholesteremic agent.
Experimental
Talviraline has been used in trials studying the treatment of HIV Infections.
Investigational
A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.
Withdrawn
Piclozotan has been investigated for the treatment of Parkinson's Disease.
Investigational
Experimental
AZD6280 has been used in trials studying the basic science of Anxiety.
Investigational
Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.
Investigational
Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase (NEP) inhibitor.
Experimental
Experimental
Displaying drugs 14076 - 14100 of 14641 in total